生物技术与制药领域的最新动态
Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S. - PR Newswire
Roche touts early giredestrant success | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Roche boosts Olema as breast cancer therapy succeeds in late-stage trial - Seeking Alpha
New experimental drug could transform care for cancer patients - The Independent
Roche Shares Rise After Breast-Cancer Pill Shows Positive Results in Trial - The Wall Street Journal
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? - simplywall.st
Roche reports positive Phase III data of giredestrant for breast cancer - Clinical Trials Arena
Roche oral drug shown to keep breast cancer at bay, boosting shares - Reuters
Roche Gives Glimpse of Cancer Genomics Potential of New Axelios Sequencer - GenomeWeb
Obituary information for Kathleen M. Roche - Cartmell Davis Funeral Home
Ice Bears swap Finstrom for blue liner Roche - Knoxville Ice Bears
Roche’s fenebrutinib shows best-in-disease potential in MS - European Pharmaceutical Review
Roche sizes up first BTK inhibitor approval on Phase III MS victory - Clinical Trials Arena
Artificial Intelligence at Roche Diagnostics - Emerj Artificial Intelligence Research
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed - Fierce Biotech
Roche Just Unleashed a Drug That Could Disrupt the Entire MS Market - Yahoo Finance
Why Roche Holding Stock Popped Today - Yahoo Finance
Roche's experimental MS drug hits main goal in one of two key trials - Reuters
Roche’s MS tablet scores in late-stage studies - BioPharma Dive
Roche Rival Plunges On 'Unprecedented' Results In MS Treatment - Investor's Business Daily